SCHEMBL26016972

SCHEMBL26016972

CCn1c(-c2ccccc2C)[n+](C)c2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.41
ATM Q13315 1/20 0.37
APOBEC3A P31941 3/20 0.37
APOBEC3G Q9HC16 3/20 0.37
RGS12 O14924 2/20 0.37
ERAP1 Q9NZ08 1/20 0.37
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 3/20 0.36
MAPT P10636 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PKM P14618 3/20 0.36
GAA P10253 1/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HTT P42858 2/20 0.35
LMNA P02545 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 2/20 0.35
APAF1 O14727 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26016975 0.84 PTPN1 (0.38) PTPN1ATMAPOBEC3AAPOBEC3GRGS12
SCHEMBL26026597 0.83 ERAP1 (0.43) PTPN1ERAP1ALDH1A1KDM4EMAPT
SCHEMBL26017015 0.79 RGS12 (0.40) PTPN1ATMAPOBEC3AAPOBEC3GRGS12
SCHEMBL13173905 0.79 ERAP1 (0.54) PTPN1ERAP1ALDH1A1KDM4EMAPT
Bromide SCHEMBL10612000 0.79 APOBEC3A (0.35) PTPN1ATMAPOBEC3AAPOBEC3GRGS12
SCHEMBL26017016 0.78 RGS12 (0.42) PTPN1APOBEC3AAPOBEC3GRGS12ALDH1A1
SCHEMBL26379022 0.78 PTPN1 (0.39) PTPN1ATMERAP1ALDH1A1KDM4E
SCHEMBL3457692 0.76 ATM (0.52) PTPN1ATMAPOBEC3AAPOBEC3GRGS12
SCHEMBL26845885 0.76 KDM4E (0.35) PTPN1APOBEC3AAPOBEC3GRGS12ERAP1
SCHEMBL25445452 0.75 KDM4E (0.38) PTPN1ATMERAP1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365606-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-11-16 US disclosed
US-11713333-B2 Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11713333-B2 Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound ORC3, LAGE3, ORMDL3 PTPN1 4355/4885ATM 1806/4885APOBEC3A 1243/4885
US-20230365606-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OXER1, OPRD1, OXSR1 PTPN1 3318/4885ATM 3650/4885APOBEC3A 4349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.